PDL BioPharma Inc names Glenn Reicin as senior advisor

Zdroj: EquityBites (M2). 06/25/2013.
Abstrakt: Monoclonal antibodies company PDL BioPharma Inc (NasdaqGS:PDLI) revealed on Tuesday the addition of Glenn M. Reicin as its senior advisor.
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje